piribedil has been researched along with Retinal Degeneration in 1 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perdriel, G | 1 |
| Chevaleraud, JP | 1 |
| Decroix, G | 1 |
1 other study available for piribedil and Retinal Degeneration
| Article | Year |
|---|---|
[Value of piribedil in the treatment of degenerative retinal vasculopathies].
Topics: Adult; Aged; Arteriosclerosis; Choroid; Drug Evaluation; Follow-Up Studies; Humans; Long-Term Care; | 1974 |